Pharma Knowledge Layer · Global Orphan Drug Access Intelligence
OrphanDrug
OrphanDrug
Pharma Knowledge Base
DrugsDiseasesCountriesPathwaysProgramsSuppliersAPI Docs

Navigation

DrugsDiseasesCountriesPathwaysProgramsSuppliersAPI Docs

About

OrphanDrug covers global rare drug access intelligence for 193 countries.

HomeAccess Programs

Drug Access Programs

5 programs
Clear
AllNamed PatientCompassionate UseEarly AccessExpanded AccessSpecial Access
Indonesia Special Access Scheme
Framework: Government Regulation No. 72/1998
Patient with serious or life-threatening condition, no registered alternative available
Special Access30d
Malaysia Special Access Scheme
Framework: Malaysian Drug Control Authority Act 1984
Patient with serious or life-threatening condition, no registered alternative available
Special Access14d
Singapore Special Access Route
Framework: Health Products Act
Patient with serious or life-threatening condition, no registered alternative available
Special Access7d
Special Access Program – Canada
Framework: Food and Drug Regulations C.08.010
Patient with serious or life-threatening condition, no registered alternative available
Special Access5d
TGA Special Access Scheme – Australia
Framework: Therapeutic Goods Act 1989
Patient with serious or life-threatening condition, no registered alternative available
Special Access28d
OrphanDrug — Global Pharma Knowledge Base
DrugsDiseasesCountriesPathwaysProgramsSuppliersAPI Docs|Terms of UsePrivacy Policy